Literature DB >> 31465985

Different magnetic resonance imaging features between MOG antibody- and AQP4 antibody-mediated disease: A Chinese cohort study.

Chen Chen1, Chunxin Liu1, Ling Fang2, Yan Zou2, Hengfang Ruan1, Yuge Wang1, Chunping Cui1, Xiaobo Sun1, Lisheng Peng1, Wei Qiu3.   

Abstract

Few studies have compared radiological features obtained on magnetic resonance imaging (MRI) between myelin oligodendrocyte glycoprotein antibody (MOG-ab)- and aquaporin 4 antibody (AQP4-ab)-positive patients. In this study, 77 MOG-ab and 92 AQP4-ab patients were enrolled. The results demonstrated that the brain MRI-based incidence of subcortical white matter lesions was higher in MOG-ab patients (p < .000) than in AQP4-ab patients and that the former therefore had a higher incidence of periventricular lesions (p = .003). The posterior limb of the internal capsule was more prone to lesions in MOG-ab patients (p = .019). Large lesions and U- or S-shaped lesions were also more frequent in MOG-ab (p < .000 and p = .013, respectively). Half of the MOG-ab patients had spinal cord involvement, and 36.5% presented with longitudinally extensive transverse myelitis (LETM). However, among the MOG-ab and AQP4-ab patients with spinal attack, there was no significant difference in the proportion with LETM (p = .057). In conclusion, a higher proportion of MOG-ab patients than AQP4-ab patients had brain lesions in white matter. Among MOG-ab patients who had an attack in the spinal cord, 65.5% also had LETM during the disease course. Conus medullaris lesions were rare in Chinese MOG-ab patients.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Aquaporin 4; Central nervous system; Lesion; Magnetic resonance imaging; Myelin oligodendrocyte glycoprotein

Year:  2019        PMID: 31465985     DOI: 10.1016/j.jns.2019.116430

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  4 in total

1.  Anti-IL-6 Therapies for Neuromyelitis Optica Spectrum Disorders: A Systematic Review of Safety and Efficacy.

Authors:  Itay Lotan; Richard McGowan; Michael Levy
Journal:  Curr Neuropharmacol       Date:  2021       Impact factor: 7.363

2.  Comparative analysis of clinical and imaging data between patients with myelin oligodendrocyte glycoprotein antibody disease and patients with aquaporin 4 antibody-positive neuromyelitis optica spectrum disorder.

Authors:  Haojie Xie; Yingzhe Shao; Juan Du; Yajun Song; Yanfei Li; Ranran Duan; Yaobing Yao; Zhe Gong; Junfang Teng; Yanjie Jia
Journal:  J Neurol       Date:  2021-08-12       Impact factor: 4.849

3.  Structural and Functional Alterations in Visual Pathway After Optic Neuritis in MOG Antibody Disease: A Comparative Study With AQP4 Seropositive NMOSD.

Authors:  Chenyang Gao; Zhizheng Zhuo; Yunyun Duan; Yajun Yao; Lei Su; Xinghu Zhang; Tian Song
Journal:  Front Neurol       Date:  2021-06-09       Impact factor: 4.003

4.  Brain structural alterations in MOG antibody diseases: a comparative study with AQP4 seropositive NMOSD and MS.

Authors:  Yunyun Duan; Zhizheng Zhuo; Haiqing Li; De-Cai Tian; Yuxin Li; Liqin Yang; Chenyang Gao; Tian Zhang; Xinghu Zhang; Fu-Dong Shi; Frederik Barkhof; Yaou Liu
Journal:  J Neurol Neurosurg Psychiatry       Date:  2021-03-09       Impact factor: 10.154

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.